An intravenous (IV) fluid shortage in the wake of Hurricane Helene is continuing after a major North Carolina factory was ...
On track to report interim data in six-month evaluable patients in ADVANCED-2 trial of TARA-002 in NMIBC in 4Q 2024Expect to report interim ...
As the nation’s largest supplier of intravenous fluids works to return to full production in North Carolina, Self Regional ...
The home infusion industry is experiencing significant growth due to the increasing number of aging patients wanting to ...
A recent shortage of intravenous solutions underscores the need to address the fragile supply chain for infusion therapy ...
ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) research with a focus on healthy aging, today announced the nationwide rollout of its ...